Minimally Invasive of Proximal Humerus Fractures With Internal Fixation Improves Shoulder Function in Older Patients

May 24, 2016 updated by: Tao Wu, Qinghai University

Minimally Invasive Treatment of Proximal Humerus Fractures With Locking Compression Plate Improves Shoulder Function in Older Patients: Study Protocol for a Prospective Randomized Controlled Trial

This study protocol represents an attempt to objectively choose appropriate methods for internal fixation of proximal humerus fractures in older patients by comparing locking compression plate with conventional steel plate fixation to improve shoulder function.

Study Overview

Detailed Description

Treatment for proximal humerus fractures emphasizes the restoration of shoulder function. Older patients, because of the loss of bodily functions, face enormous difficulties in fracture healing and shoulder functional recovery after sustaining proximal humerus fractures. As previously reported, open reduction with conventional locking plate fixation achieved fair outcomes in 48 cases of proximal humerus fractures in older patients, with an excellent rate of 85.4% according to the Neer classification system. The investigators' clinical experience, however, has shown that the stability of internal fixation is inadequate and must be enhanced. Consequently, the investigators design a microsurgical implantation using a locking compression plate (LCP) to treat proximal humerus fractures in older patients.

In a search of the Web of Science database, the investigators found a randomized controlled trial reported by Wang et al. in which LCP fixation using microsurgical techniques had better outcomes in 20 cases of proximal humerus fractures in older patients. However, the limitation created by the small sample size had profound effects on the reliability of their study.

No relevant articles were retrieved from the Chinese Clinical Trial Register, and only one similar article was found on ClinicalTrials.gov: "Proximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts" (identifier: NCT01984112). In this clinical trial, Constant-Murley scores were considered the primary outcome, and the follow-up period was 12 months. Importantly, the inclusion criteria and study arms were distinctly different from those in the investigators' study protocol.

The main principle of minimally invasive techniques in orthopedics is to implant a specific bony plate, which is fixed across a transverse fracture, via small incisions of the periosteum, skin, and muscle. These implantation devices include less invasive stabilization systems, dynamic compression plate systems, and LCP systems. Internal fixation with the LCP system involves two completely different fixation techniques and two opposing osteosynthesis principles, namely conventional plate and bridging plate osteosyntheses characterized by direct anatomical reduction. Because of its special design, the LCP can be used as a dynamic compression plate, as a pure internal fixator using locking head screws, or as both combined, thus providing a variety of therapeutic options for surgeons. Moreover, the LCP has good stability and induces less damage to the periosteum; it is therefore beneficial for bone healing and functional recovery. Given these characteristics, the LCP is likely to have stronger stability than the conventional locking plate for internal fixation of fractures. Therefore, the investigators design a study protocol that compares the LCP and conventional locking plate using minimally invasive techniques for internal fixation of proximal humerus fractures in older patients. The investigators hypothesize that the LCP will be more effective than the conventional locking plate in promoting shoulder function recovery with a higher excellent rate according to the Neer classification system for proximal humerus fractures.

Data collection, management, analysis, and open access

  • Data collection: All data, including demographic information, disease diagnosis, concomitant diseases, allergic history (drug allergy), and adverse reactions, will be collected on a case report form and summarized in one form. These data will be recorded electronically using a double-data entry strategy by EpiData software.
  • Data management: Only the project manager will have the right to query the database, and changes will not be allowed. All data relevant to this clinical trial will be preserved by the Affiliated Hospital of Qinghai University.
  • Data analysis: All data will be statistically analyzed by professional statisticians. The statistical report by the statisticians will be given to the project manager responsible for writing the research report. An independent data monitoring committee will be in charge of data monitoring and management throughout the entire trial to ensure scientific accuracy, authenticity, and integrity.
  • Open data: Published data will be released at www.figshare.com.

Statistical analysis The statistical analysis will be completed by statisticians using the SPSS 19.0 statistical software (IBM Corp., Armonk, NY, USA) in line with the intention-to-treat principle. Intergroup comparison for the excellent rate according to the Neer classification system will be performed using the chi-square test. The operation time, intraoperative blood loss, postoperative hospital stay, fracture healing time, visual analogue scale scores, and SF-36 scores will be compared using the Mann-Whitney U test. A value of P < 0.05 will be considered statistically significant.

Adverse events

  • Predicted and unanticipated adverse events will be recorded during the trial.
  • Adverse events including dizziness, fever, infection, subacromial impingement, humeral head necrosis, malunion, and severe pain will be detected.
  • All serious adverse events will be recorded in detail, including the date of occurrence, type of event, and treatments, all of which will be reported to the project manager and institution review board within 24 hours.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Neer II or III fractures as shown by X-ray examination
  • Presentation with soft tissue swelling of the shoulder, limited mobility, tenderness, unusual activity, or a palpable sense of bone rubbing
  • Unilateral traumatic fracture
  • Over 60 years of age
  • Admission to the hospital within 6 hours after injury
  • Informed consent from patients or their relatives

Exclusion Criteria:

  • Concomitant injuries involving pathological fracture, blood vessel injury, or nerve injury
  • Head-split humerus fractures
  • Severe comminuted proximal humerus fractures involving > 40% of the articular surface of the humeral head
  • Disturbance of consciousness, cerebral infarction, cancer, severe medical complications (such as heart, lung, or kidney failure; severe hypertension; diabetes; or blood diseases)
  • History of shoulder or elbow dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: locking compression plate group
In the experimental group, patients will undergo closed reduction via a lateral approach to the shoulder followed by locking compression plate fixation using a minimally invasive technique.The locking compression plate is purchased from Xiamen Dabo Yingjing Medical Devices Co., Ltd., Xiamen, China.
Closed reduction via shoulder lateral approach followed by locking compression plate fixation using minimally invasive technique
Active Comparator: conventional locking plate group
Patients in the control group will be subjected to closed reduction via a lateral approach to the shoulder followed by conventional steel plate fixation using a minimally invasive technique. The conventional locking plate is purchased from Xiamen Dabo Yingjing Medical Devices Co., Ltd., Xiamen, China.
Closed reduction via shoulder lateral approach followed by conventional locking plate fixation using minimally invasive technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neer classification system score
Time Frame: month 6 after surgery
Clinical outcome scores according to the Neer classification system will be used to assess shoulder function recovery.
month 6 after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of visual analogue scale score
Time Frame: day 1, day 3 and week 1, week 2 after surgery
Visual analogue scale scores assess postoperative pain relief.
day 1, day 3 and week 1, week 2 after surgery
change of X-ray examinations
Time Frame: month 0.5, month 1, month 3, and month 6 after surgery
Disappearance of the fracture line shown on X-ray examination indicates fracture healing.
month 0.5, month 1, month 3, and month 6 after surgery
Change of Medical Outcomes Study 36-item Short Form Health Survey (SF-36) Score
Time Frame: month 0.5, month 1, month 3, and month 6 after surgery
month 0.5, month 1, month 3, and month 6 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tao Wu, Master, Affiliated Hospital of Qinghai University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 19, 2016

First Submitted That Met QC Criteria

May 24, 2016

First Posted (Estimate)

May 27, 2016

Study Record Updates

Last Update Posted (Estimate)

May 27, 2016

Last Update Submitted That Met QC Criteria

May 24, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • QinghaiUH_001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Humerus Fractures

Clinical Trials on locking compression plate group

Subscribe